---
figid: PMC3081913__nihms256586f2
figlink: /pmc/articles/PMC3081913/figure/F2/
number: F2
caption: 'Normally, cell proliferation is controlled by growth factors binding to
  receptor tyrosine kinase with sequential activation of Ras → Raf-1→ MEK → ERK to
  induce cell proliferation. There is a phenotypic difference between normal kidney
  cells and PKD cells in the cAMP effect on proliferation. (A) In normal human kidney
  (NHK) cells, basal Ca2+ levels, regulated by a variety of Ca2+ entry mechanisms,
  including the PC1/PC2 complex, maintain the activity of PI3 kinase/Akt pathway which
  represses B-Raf. B-Raf kinase activity is inhibited by Akt phosphorylation of an
  inhibitory site. cAMP agonists, i.e. AVP, inhibit Raf-1, ERK and cell proliferation
  through a PKA-dependent mechanism. Thus, in normal renal cells, the balance of positive
  and negative signals control Raf-1 signaling to ERK activation and cell proliferation.
  (B) By contrast, in PKD cells a reduction in intracellular Ca2+ levels due to a
  loss of PC1/PC2 function relieves Akt inhibition of B-Raf, allowing cAMP to signal
  through B-Raf to activate MEK and ERK and to stimulate cell proliferation. [Adapted
  from Cowley, Kidney Int. 73:251–253, 2008; and Yamaguchi et al., J. Am. Soc Nephrol
  17: 178–187, 2006]'
pmcid: PMC3081913
papertitle: Cyclic AMP-Mediated Cyst Expansion.
reftext: Darren P. Wallace. Biochim Biophys Acta. ;1812(10):1291-1300.
pmc_ranked_result_index: '190718'
pathway_score: 0.9454526
filename: nihms256586f2.jpg
figtitle: Cyclic AMP-Mediated Cyst Expansion
year: ''
organisms: Homo sapiens
ndex: e368d278-def6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3081913__nihms256586f2.html
  '@type': Dataset
  description: 'Normally, cell proliferation is controlled by growth factors binding
    to receptor tyrosine kinase with sequential activation of Ras → Raf-1→ MEK → ERK
    to induce cell proliferation. There is a phenotypic difference between normal
    kidney cells and PKD cells in the cAMP effect on proliferation. (A) In normal
    human kidney (NHK) cells, basal Ca2+ levels, regulated by a variety of Ca2+ entry
    mechanisms, including the PC1/PC2 complex, maintain the activity of PI3 kinase/Akt
    pathway which represses B-Raf. B-Raf kinase activity is inhibited by Akt phosphorylation
    of an inhibitory site. cAMP agonists, i.e. AVP, inhibit Raf-1, ERK and cell proliferation
    through a PKA-dependent mechanism. Thus, in normal renal cells, the balance of
    positive and negative signals control Raf-1 signaling to ERK activation and cell
    proliferation. (B) By contrast, in PKD cells a reduction in intracellular Ca2+
    levels due to a loss of PC1/PC2 function relieves Akt inhibition of B-Raf, allowing
    cAMP to signal through B-Raf to activate MEK and ERK and to stimulate cell proliferation.
    [Adapted from Cowley, Kidney Int. 73:251–253, 2008; and Yamaguchi et al., J. Am.
    Soc Nephrol 17: 178–187, 2006]'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ADCY4
  - ADCY10
  - HRAS
  - ADCY9
  - ADCY8
  - AKT2
  - ADCY6
  - PIK3CA
  - PIK3R5
  - AKT3
  - NRAS
  - PRKAR2A
  - ADCY5
  - RAF1
  - PRKAR1A
  - ADCY3
  - AKT1
  - KRAS
  - PIK3R4
  - PRKAR2B
  - BRAF
  - ADCY1
  - ADCY2
  - MAPK3
  - MAP2K1
  - ADCY7
  - PIK3R6
  - PRKACA
  - PRKAR1B
  - PIK3CD
  - PIK3CB
  - MAPK1
  - PIK3R3
  - PRKACB
  - MAP2K2
  - PRKACG
  - PIK3CG
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: Raf-1
  symbol: Raf-1
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: B-Raf
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3081913__F2
redirect_from: /figures/PMC3081913__F2
figtype: Figure
---
